Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2015 | 3 |
2016 | 1 |
2017 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells.
Signal Transduct Target Ther. 2019 Jun 19;4:20. doi: 10.1038/s41392-019-0050-0. eCollection 2019.
Signal Transduct Target Ther. 2019.
PMID: 31240133
Free PMC article.
CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.
Astori A, Fredly H, Aloysius TA, Bullinger L, Mansat-De Mas V, de la Grange P, Delhommeau F, Hagen KM, Récher C, Dusanter-Fourt I, Knappskog S, Lillehaug JR, Pendino F, Bruserud Ø.
Astori A, et al. Among authors: hagen km.
Oncotarget. 2013 Sep;4(9):1438-48. doi: 10.18632/oncotarget.1195.
Oncotarget. 2013.
PMID: 23988457
Free PMC article.
Item in Clipboard
CDC25 Inhibition in Acute Myeloid Leukemia-A Study of Patient Heterogeneity and the Effects of Different Inhibitors.
Brenner AK, Reikvam H, Rye KP, Hagen KM, Lavecchia A, Bruserud Ø.
Brenner AK, et al. Among authors: hagen km.
Molecules. 2017 Mar 11;22(3):446. doi: 10.3390/molecules22030446.
Molecules. 2017.
PMID: 28287460
Free PMC article.
Item in Clipboard
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome.
Kittang AO, Kordasti S, Sand KE, Costantini B, Kramer AM, Perezabellan P, Seidl T, Rye KP, Hagen KM, Kulasekararaj A, Bruserud Ø, Mufti GJ.
Kittang AO, et al. Among authors: hagen km.
Oncoimmunology. 2015 Jun 24;5(2):e1062208. doi: 10.1080/2162402X.2015.1062208. eCollection 2016 Feb.
Oncoimmunology. 2015.
PMID: 27057428
Free PMC article.
Item in Clipboard
Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.
Bruserud Ø, Reikvam H, Fredly H, Skavland J, Hagen KM, van Hoang TT, Brenner AK, Kadi A, Astori A, Gjertsen BT, Pendino F.
Bruserud Ø, et al. Among authors: hagen km.
Oncotarget. 2015 Feb 20;6(5):2794-811. doi: 10.18632/oncotarget.3056.
Oncotarget. 2015.
PMID: 25605239
Free PMC article.
Item in Clipboard
The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells.
Reikvam H, Brenner AK, Hagen KM, Liseth K, Skrede S, Hatfield KJ, Bruserud Ø.
Reikvam H, et al. Among authors: hagen km.
Stem Cell Res. 2015 Nov;15(3):530-541. doi: 10.1016/j.scr.2015.09.008. Epub 2015 Sep 25.
Stem Cell Res. 2015.
PMID: 26468600
Free article.
Item in Clipboard
Cite
Cite